BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Policy

  COVID-19 Isn’t Done with Us Yet, Vaccine Patents and a 4th Booster

  Now that Omicron is becoming less common, its sister variant, BA.2, seems to be surging worldwide and in the U.S. For that and more, continue reading.

  March 16, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  Policy

  Ex-JHL Execs Sentenced For Wire Fraud and Trade Secret Theft

  Two former executives of JHL Biotech were sentenced to a year and one day each in prison after being found guilty of conspiracy and fraud.

  March 16, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Business

  Global Roundup: Oxford Hub Expanding into “Ideal Environment” for Life Sciences Companies

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  March 16, 2022

   · 

  6 min read

   · 

  Alex Keown
• 

  Drug Development

  Digital Twin Studies: the Next Inflection in Equal, Equitable, Healthcare

  The Media and Innovation Lab at the University of Miami is developing digital twins of patients in an effort to bring robust healthcare to underserved communities.

  March 16, 2022

   · 

  4 min read

   · 

  Gail Dutton
• 

  Business

  Sanofi and Seagen: a Match Made in ADC Heaven

  Healthcare giant Sanofi and cancer-focused biotech company Seagen Inc. announced an exclusive collaboration agreement to develop antibody-drug conjugates (ADCs) for cancer treatments.

  March 16, 2022

   · 

  2 min read

   · 

  Hannah Chudleigh
• 

  Policy

  Novartis, Lilly, Merck and More Halt Business Operations in Russia

  More pharmaceutical companies are joining to put economic pressure on Russia by suspending some or all operations within that country following the invasion of Ukraine.

  March 16, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Book Review: Warp Speed – One of the Most Successful Private-Public Partnerships

  In his new book, Warp Speed, Paul Mango said the realization that many healthcare workers didn’t want the vaccine, for instance, was shocking.

  March 16, 2022

   · 

  5 min read

   · 

  Gail Dutton
• 

  Business

  Shoreline Poaches Pfizer Cancer Vaccine Head, Robert Hollingsworth

  Robert Hollingsworth, PhD, a former Pfizer executive who oversaw the development of cancer vaccines and immunotherapeutics, has taken on the role of the CSO at Shoreline Biosciences.

  March 16, 2022

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Lilly, BI-Partnered Kidney Trial Stopped Early Due to Positive Results

  After reviewing the trial’s Independent Data Monitoring Committee, the EMPA-KIDNEY trial announced it would stop early as it met prespecified criteria for positive efficacy.

  March 16, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  New NurOwn Data Backs Up Importance of UNC13A in ALS

  BrainStorm Cell Therapeutics’ NurOwn has taken the amyotrophic lateral sclerosis (ALS) community by storm with new genetic data from its Phase III trial.

  March 16, 2022

   · 

  3 min read

   · 

  Heather McKenzie